FR2722786B1 - Derives de 4-hydroxy-3-phenyl-indeno(1,2-b)pyridine-2(1h)- one, leur preparation et les medicaments les contenant - Google Patents

Derives de 4-hydroxy-3-phenyl-indeno(1,2-b)pyridine-2(1h)- one, leur preparation et les medicaments les contenant

Info

Publication number
FR2722786B1
FR2722786B1 FR9408999A FR9408999A FR2722786B1 FR 2722786 B1 FR2722786 B1 FR 2722786B1 FR 9408999 A FR9408999 A FR 9408999A FR 9408999 A FR9408999 A FR 9408999A FR 2722786 B1 FR2722786 B1 FR 2722786B1
Authority
FR
France
Prior art keywords
indeno
pyridine
hydroxy
phenyl
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9408999A
Other languages
English (en)
Other versions
FR2722786A1 (fr
Inventor
Jean Claude Aloup
Francois Audiau
Michel Barreau
Dominique Damour
Borella Arielle Genevois
Patrick Jimonet
Serge Mignani
Yves Ribeill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Priority to FR9408999A priority Critical patent/FR2722786B1/fr
Priority to PCT/FR1995/000952 priority patent/WO1996002536A1/fr
Priority to JP8504757A priority patent/JPH10504027A/ja
Priority to AU29846/95A priority patent/AU2984695A/en
Priority to ZA955942A priority patent/ZA955942B/xx
Priority to EP95925892A priority patent/EP0772612A1/fr
Publication of FR2722786A1 publication Critical patent/FR2722786A1/fr
Application granted granted Critical
Publication of FR2722786B1 publication Critical patent/FR2722786B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9408999A 1994-07-20 1994-07-20 Derives de 4-hydroxy-3-phenyl-indeno(1,2-b)pyridine-2(1h)- one, leur preparation et les medicaments les contenant Expired - Fee Related FR2722786B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR9408999A FR2722786B1 (fr) 1994-07-20 1994-07-20 Derives de 4-hydroxy-3-phenyl-indeno(1,2-b)pyridine-2(1h)- one, leur preparation et les medicaments les contenant
PCT/FR1995/000952 WO1996002536A1 (fr) 1994-07-20 1995-07-17 Derives de 4-hydroxy-3-phenyl-indeno(1,2-b)pyridine-2(1h)-one comme nmda antagonistes
JP8504757A JPH10504027A (ja) 1994-07-20 1995-07-17 ＮＭＤＡ拮抗物質としての４−ヒドロキシ−３−フェニル−インデノ（１，２−ｂ）ピリジン−２（１Ｈ）−オン誘導体類
AU29846/95A AU2984695A (en) 1994-07-20 1995-07-17 4-hydroxy-3-phenyl-indeno(1,2-b)pyridine-2(1h)-one derivatives as nmda antagonists
ZA955942A ZA955942B (en) 1994-07-20 1995-07-17 4-hydroxy-3-phenylindeno[1,2-b]pyridin-2(1H)-one derivatives their preparation and the medicaments containing them
EP95925892A EP0772612A1 (fr) 1994-07-20 1995-07-17 Derives de 4-hydroxy-3-phenyl-indeno(1,2-b)pyridine-2(1h)-one comme nmda antagonistes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9408999A FR2722786B1 (fr) 1994-07-20 1994-07-20 Derives de 4-hydroxy-3-phenyl-indeno(1,2-b)pyridine-2(1h)- one, leur preparation et les medicaments les contenant

Publications (2)

Publication Number Publication Date
FR2722786A1 FR2722786A1 (fr) 1996-01-26
FR2722786B1 true FR2722786B1 (fr) 1996-08-23

Family

ID=9465588

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9408999A Expired - Fee Related FR2722786B1 (fr) 1994-07-20 1994-07-20 Derives de 4-hydroxy-3-phenyl-indeno(1,2-b)pyridine-2(1h)- one, leur preparation et les medicaments les contenant

Country Status (6)

Country Link
EP (1) EP0772612A1 (fr)
JP (1) JPH10504027A (fr)
AU (1) AU2984695A (fr)
FR (1) FR2722786B1 (fr)
WO (1) WO1996002536A1 (fr)
ZA (1) ZA955942B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1368355B1 (fr) * 2001-03-14 2006-06-07 Grünenthal GmbH Pyrazolopyrimidines et thiazolopyrimidines substituees
WO2015088565A1 (fr) * 2013-12-13 2015-06-18 Sunovion Pharmaceuticals Inc. Composés modulateurs du récepteur p2x4 et leurs procédés d'utilisation
WO2015088564A1 (fr) * 2013-12-13 2015-06-18 Sunovion Pharmaceuticals Inc. Composés modulateurs du récepteur p2x4

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ233641A (en) * 1989-05-16 1992-07-28 Merrell Dow Pharma Quinoline and thienopyridine derivatives and excitatory amino acid antagonistic pharmaceutical compositions
GB9022785D0 (en) * 1990-10-19 1990-12-05 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
FR2722786A1 (fr) 1996-01-26
WO1996002536A1 (fr) 1996-02-01
EP0772612A1 (fr) 1997-05-14
AU2984695A (en) 1996-02-16
JPH10504027A (ja) 1998-04-14
ZA955942B (en) 1996-02-21

Similar Documents

Publication Publication Date Title
MA26685A1 (fr) Derives d'azetidine leur preparation et les medicaments les contenant
MA26479A1 (fr) Derives de nicotinamide, procede pour leur preparation et compositions pharmaceutiques les contenant
PT80921A (fr) Procede de preparation de derives d'acylaminomethyl-3-imidazo<1,2-a>pyridines et de compositions pharmaceutiques les contenant
FR2735777B1 (fr) Derives de 4-phenylaminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
FR2582309B1 (fr) Nouveaux derives du morphinane et de la morphine, leur preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant
FR2645152B1 (fr) 3h-pteridinones-4, procedes de preparation et medicaments les contenant
FR2722190B1 (fr) Derives de 1-benzyl-1,3-dihydro-2h-benzimidazol-2-one, leur preparation, les compositions pharmaceutique en contenant
PT76573A (fr) Procede de preparation de derives d'imidazo <1,2-a> pyridine et de compositions pharmaceutiques les contenant
FR2628425B1 (fr) Derives d'isoindolinone, leurs procedes de preparation et les medicaments les contenant
MA26413A1 (fr) DERIVES D'OCTAHYDRO-PYRROLO [1,2-a] PYRAZINE 2,7-SUBSTITUES, PROCEDE POUR LEUR PREPARATION ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT
FR2717811B1 (fr) Dérivés d'imidazo[1,2-a]pyrazine-4-one, leur préparation et les médicaments les contenant.
FR2593818B1 (fr) Derives d'acylaminomethyl-3 imidazo(1,2-a)pyridine, leur preparation et leur application en therapeutique
FR2743366B1 (fr) Derives de 5h,10h-imidazo(1,2-a)indeno(1,2-e)pyrazine-4-one, leur preparation, leurs intermediaires et les medicaments les contenant
FR2641276B1 (fr) Derives du benzene, leur preparation et les compositions pharmaceutiques en contenant
FR2722786B1 (fr) Derives de 4-hydroxy-3-phenyl-indeno(1,2-b)pyridine-2(1h)- one, leur preparation et les medicaments les contenant
FR2732681B1 (fr) Derives de 10h-imidazo(1,2-a)indeno(1,2-e)pyrazin-4-one, leur preparation et les medicaments les contenant
FR2565586B1 (fr) Derives de la naphtoxazine, leur preparation, leur application comme medicaments et compositions pharmaceutiques les contenant
FR2593817B1 (fr) Derives de tetrahydro-5,6,7,8 imidazo(1,2-a)pyridine, leur preparation et leur application en therapeutique
FR2738821B1 (fr) Indeno[1,2-e]pyrazin-4-ones, leur preparation et les medicaments les contenant
FR2733984B1 (fr) Derives de tryptamine, leur preparation et les medicaments les contenant
FR2673944B1 (fr) Derives de l'1,8-naphtalimide, leur procede de preparation et les compositions pharmaceutiques les contenant.
FR2649981B1 (fr) Derives de dihydropyrimidothiazine, leur procede de preparation et compositions pharmaceutiques les contenant
FR2766181B1 (fr) Derives de polyhydroxybutylpyrazines, leur preparation et les medicaments les contenant
FR2659334B1 (fr) Derives de n-phenyl glycinamide, leur preparation et les medicaments les contenant.
BE874154A (fr) Derives de l'eburnamonine, leur preparation et medicaments contenant ces substances

Legal Events

Date Code Title Description
ST Notification of lapse